openPR Logo
Press release

SkipClass Is Leading the Shift From Traditional Education to AI-Driven Upskilling

07-31-2025 02:32 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

SkipClass Is Leading the Shift From Traditional Education

SkipClass.ai [http://skipclass.ai], an AI-powered learning platform built to help ambitious young professionals and learners master high-leverage skills like sales, coding, finance and others, officially launched out of stealth. Founded by Raphael Assor, a former military service member and a self-taught software engineer, and Jared Zelman, a recent USC graduate, SkipClass is leading a new wave of AI learning that emphasizes active self-learning, simulation-based experiences, and skill-building rooted in real-world performance, not passive video watching.

Designed for the modern, self-driven learner, SkipClass blends proprietary AI [https://skipclass.ai/#how-it-works] with exclusive insights from some of the world's most respected thinkers and leaders. These include simulated AI professors modeled after exclusive content from experts like Robin Sharma, Richard Dawkins, Jimmy Carr, and George Church, capturing not just what they know, but how they think and teach.

"We help young professionals master high-level skills through real-world simulations, instant feedback, and personalized coaching from AI versions of the world's top thinkers and operators," said Assor.

SkipClass was originally launched in 2024 as an AI research lab focused on performance-based learning design. The team quickly realized that today's learners weren't looking for another educational subscription; they wanted on-demand mastery, optimized for upskilling, execution, and long-term retention.

"Modern education is still too passive," said Zelman. "We're building a new operating system for learning, something designed for speed, relevance, and mastery. Whatever your situation may be, SkipClass is for people who want to skip the fluff and level up fast."

Unlike traditional edtech platforms that serve enterprises or institutions, SkipClass.ai is a consumer-first product. It's designed for ambitious professionals and young learners looking to skip outdated methods and go straight to mastery on their own time, at their own pace.

Rather than relying on videos, lectures, or flashcards, SkipClass puts learners into immersive learning environments driven by AI professors. These experiences simulate real-world challenges [https://app.skipclass.ai/onboard], from negotiating deals to debugging code, paired with instant, contextual feedback. It's education built for performance, not just consumption.

As SkipClass exits stealth mode, the company plans to expand its roster of AI mentors, deepen its personalization engine, and strengthen its university collaborations-all while continuing to build a new standard for AI-powered skill building.

Media Contact
Company Name: SkipClass
Contact Person: Jared Zelman
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=skipclass-is-leading-the-shift-from-traditional-education-to-aidriven-upskilling]
Country: United States
Website: https://skipclass.ai/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SkipClass Is Leading the Shift From Traditional Education to AI-Driven Upskilling here

News-ID: 4128406 • Views:

More Releases from ABNewswire

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the Retinal Vein Occlusion pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Retinal Vein Occlusion pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore

All 5 Releases